Sign in
4

Changes in Ownership

BIOMARIN PHARMACEUTICAL INC Filed Acc 0001567619-23-005285

Chief Executive Officer gave up 98,060 shares (to pay taxes)

  • Chief Executive Officer acquired 36,100 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BIENAIME JEAN JACQUES · Chief Executive Officer

Table I: Non-derivative

3 lines
Date Transaction Shares Price Value Owned after D/I
2023-03-15 Grant or award : show line 1 in the form +36,100 523,956 D
2023-03-15 Shares withheld for taxes : show line 2 in the form −9,437 $87.74 $828,002 514,519 D
2023-03-16 Shares withheld for taxes : show line 3 in the form −88,623 $93.41 $8,278,274 425,896 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-03-15 Grant or award : show line 4 in the form Stock Option (Right to buy Common Stock) +49,430 49,430 D
Loading xslF345X03/doc1.xml…